Diagnostically, HLH may present a challenge as there is an overlap of some of its presenting signs and symptoms with CRS; a high index of suspicion is required for prompt diagnosis, and both corticosteroids and anti-cytokine therapy with an IL-6 antagonist have been used in CAR T cell patients [38]. The gene discussed is IL6; the disease is congenital rubella syndrome.